Approval · Notice of Compliance 37102 · 2026
PLENDIL: Notice of Compliance 37102
Issued March 13, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37102
- Date
- March 13, 2026
- Company
- Glenwood Gmbh Pharmazeutische ErzeugnisseMunich, --, Germany
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a drug product manufacturing site and/or manufacturer involving production
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PLENDIL | Not yet assigned | — |
Medicinal ingredients
- FELODIPINE 2.5 MG per TAB
- FELODIPINE 5 MG per TAB
- FELODIPINE 10 MG per TAB